Sagimet Biosciences Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Sagimet Biosciences Inc. reported Cash And Cash Equivalents At Carrying Value of $35.02 million for the year ending 2025.

  • Sagimet Biosciences Inc. showed a decrease of -53.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Sagimet Biosciences Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), Sagimet Biosciences Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 22,065.2%.
  • Historical annual values: Fiscal year 2025: $35.02 million | Fiscal year 2024: $75.84 million | Fiscal year 2023: $75.14 million | Fiscal year 2022: $158.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: